Sinofn Health
Sinofn Health
Discover our highly uniform dose-delivery matrices, manufactured in certified high-tech facilities to guarantee ingredient consistency in every batch.
In modern preventative medicine and advanced nutritional supplementation, Content Uniformity (CU) serves as the absolute baseline for product safety, therapeutic efficacy, and brand integrity. When dealing with micro-dose actives—such as NMN, PQQ, Vitamin D3, or specialized amino acids for metabolic disorders like Phenylketonuria (PKU)—even a minor deviation in blending homogeneity can lead to sub-therapeutic dosing or toxic overexposure.
As a leading national high-tech enterprise partnered directly with the Chinese Academy of Sciences (CAS), SINOFN Health Co., Ltd. has engineered next-generation blending, granulation, and tableting processes. By minimizing the Relative Standard Deviation (RSD) below the rigorous pharmaceutical threshold of 3%, we guarantee that every single unit dose—be it a tablet, softgel, powder sachet, or oral liquid—contains precisely what is declared on the label.
Traditional manufacturing relies on simple random bulk analysis. SINOFN introduces Process Analytical Technology (PAT) using real-time Near-Infrared (NIR) spectroscopy. This allows us to validate powder blends non-destructively in-line, ensuring perfect spatial dispersion of microscopic compounds within complex multi-ingredient formulations before compressing or packaging.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of the SINOFN Group. Founded in 2012, backed by elite scientists and substantial venture support, our manufacturing facilities occupy over 53,000 square meters of state-of-the-art space. In 2025, we established our corporate export hub in Shanghai to streamline global partnerships, logistics, and compliance support for premium brands across North America, Europe, and the Asia-Pacific region.
During her distinguished clinical work, Mrs. GuoHong Liu witnessed the lifelong metabolic struggles of children diagnosed with Phenylketonuria (PKU). At the time, importing specialized medical diets was financially devastating for many families. Driven by a mission to bridge this critical gap, Mrs. Liu founded SINOFN in 2012 to develop affordable, science-backed metabolic formulations.
Her commitment to excellence attracted high-tier strategic investors and fueled massive technological transformation:
"We measure success not just in raw export volume, but in the number of lives improved through accessible, reliable molecular science." – Mrs. GuoHong Liu
SINOFN combines elite academic research with industrial-scale execution, featuring researchers from the Chinese Academy of Sciences and international regulatory specialists.
Ph.D. from Peking University Medical School. 15+ years of specialized experience in clinical metabolic disorder formulations and therapeutic nutrition design.
Associate Researcher, CAS Postdoctoral Fellow. A pioneer in micro-ingredient delivery technologies, specializing in lipid-based nano-emulsions and bioavailability enhancement.
Senior Scientist from the Netherlands. A world-class specialist in European regulatory frameworks and complex dry-blending manufacturing systems.
As micro-dosed dietary supplements become more targeted, traditional manufacturing methods fail to deliver the required precision. SINOFN is executing a multi-stage technology roadmap designed to completely eliminate dosage variance.
Utilizing highly specialized multi-stage geometric dilution protocols to ensure that high-potency ingredients (such as PQQ or Melatonin) are systematically integrated into excipient matrices without hot spots.
By implementing real-time Near-Infrared sensors in our blending chambers, we monitor active ingredient distribution throughout the blending process, allowing for automated cycle adjustments.
Developing natural carrier alternatives (like organic rice extract and sunflower lecithin) that achieve identical flowability and dispersion performance as synthetic flow agents.
Tour our world-class manufacturing complex designed to meet the strictest standards of global food safety and pharmaceutical manufacturing.
Features 10+ high-capacity dedicated lines for softgels, gummies, tablets, and powders. Annual capacity exceeds 500 million units.
Equipped with HPLC, GC-MS, and ICP-MS systems for heavy metals, pesticides, and active chemical assays.
Pilot-scale lines allowing seamless scaling of complex dosage forms while validating bioavailability parameters.
From raw storage to final packaging under continuous environmental control, backed by blockchain batch tracking.
SINOFN leverages modern automated automation and deep vertical integration to secure global supply chain continuity and cost efficiency.
Global regulatory bodies, including the US FDA, EFSA, and China's NMPA, are continuously updating requirements for dietary supplements, demanding higher standardization. SINOFN meets these evolving requirements by aligning all manufacturing practices with international pharmaceutical standards.
We work closely with global procurement teams to optimize sourcing efficiency through clear, reliable service protocols:
SINOFN operates under a comprehensive quality management system validated by leading global auditing bodies.
Get detailed technical insights about our capabilities, quality control processes, and supply chain logistics.
Our main production facilities are located in Tianjin and Shandong province, China, covering over 53,000 square meters. Our international business division is located in Shanghai to provide seamless logistics, export support, and client services to brands globally.
We use a multi-stage geometric dilution process combined with specialized high-shear dry blending machinery. Furthermore, our R&D team analyzes sample batches using HPLC (High-Performance Liquid Chromatography) testing to guarantee a Relative Standard Deviation (RSD) below 3%, matching strict pharmaceutical parameters.
Yes. Led by Dr. Tan Shengjie and Dr. Zhang Ying, our R&D center features a pilot-scale facility where we formulate, manufacture, and test small trial batches of tablets, capsules, liquids, and powders to validate bioavailability and flavor stability before mass production.
Yes, we support businesses of all sizes. We offer flexible low-MOQ trial programs for startups wishing to validate new product ideas, while maintaining the production capacity and quality certifications needed by major global brands.
We are fully certified under ISO 9001, ISO 22000, HACCP, FSSC 22000, and HALAL. All manufacturing lines comply strictly with GMP guidelines, and our logistics and warehousing systems are certified by BRCGS.
Yes. SINOFN was founded on our research into specialized medical diets for PKU (Phenylketonuria). We offer highly specialized amino acid blends free from phenylalanine, custom formulated for different age groups (infants under 12 months, and children aged 1 to 10).
Browse our wide range of premium wellness and high-performance product solutions designed for global export.
